The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal

MLA

C. R. Harley, et al. “The Comparative Effectiveness of Rosuvastatin vs. Other Statins in Patients with an Increased Risk of Failure to Reach NCEP ATP III Goal.” International Journal of Clinical Practice, vol. 62, June 2008, pp. 889–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........dca185827f65e73c1e665c21022ecb5e&authtype=sso&custid=ns315887.

APA

C. R. Harley, H. Heien, Sanjay Gandhi, & S. P. Nelson. (2008). The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal. International Journal of Clinical Practice, 62, 889–895.

Chicago

C. R. Harley, H. Heien, Sanjay Gandhi, and S. P. Nelson. 2008. “The Comparative Effectiveness of Rosuvastatin vs. Other Statins in Patients with an Increased Risk of Failure to Reach NCEP ATP III Goal.” International Journal of Clinical Practice 62 (June): 889–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........dca185827f65e73c1e665c21022ecb5e&authtype=sso&custid=ns315887.